All Type of News
Battle looms over Plavix and Lipitor market
Korea’s major drug makers and two multinational companies – Pfizer and Sanofi-Aventis - are set for a fresh battle for leadership in the domestic prescription Plavix and Lipitor markets.
1) Plavix
The country's ge...
Hanmi, emerging as strong competitor in domestic generic market
Hanmi Pharm is expected to grab bigger pie in the nation’s generic market where many players are rushing to introduce first generic versions of off-patent drugs, according to a local analyst.
Kim Tae-hee, an analys...
Government mulls earlier implementation of pharmacy college’s six-year course plan
The government is considering implementing pharmacy college’s six-year courses from 2010, one year earlier than original plan, according to the Ministry of Education, Science and Technology.
“We are now under consu...
KFDA approves Ahngook’s cough medicine
Ahngook says the Korea Food and Drug Administration has approved its cough medicine theobromine 300 mg capsule (trade name: Anycough).
A cough medicine is a medicinal drug used to treat coughing and related conditi...
Johnson & Johnson's four affiliated firms moving to one building
Janssen Korea, Johnson & Johnson Korea, Johnson & Johnson Medical Korea and VisionCare have been incorporated into a 28-story LS Tower building in Yongsan District.
A total of 1,000 employees may enjoy easier commu...
Korean pharmaceutical firms seeking to acquire promising bioventure companies
Domestic drug makers are focusing on investment or acquisition for promising biopharmaceutical companies with platform technologies as part of efforts to survive in an era of free trade deals with foreign countries.
...
Annual medication costs up 14% on average
Korea’s drug costs have risen an average 14.3 percent for the recent five years, according to a report released by the Health Insurance Review Agency.
The report shows that the national health insurance spent 9.2 t...
Lilly Korea announces KFDA approval of exenatideLilly Korea announce that the Korea Food and Drug Administration has approved exenatide as adjunctive therapy to improve blood sugar control in patients with type 2 diabetes who...
|
EDQM approves EstechPharma’s acamprosate calcium
EstechPharma says the European Directorate for Quality Medicines (EDQM) has certified its acamprosate calcium, anti-alcoholic medicine.
With the EDQM’s approval of acamprosate calcium, the company is poised to make...
KFDA officials aghast over reorganization plan
The government reorganization plan reflected President’s Lee Myung-bak's push for a leaner, efficient government but was met with disappointment and protests from the Korea Food and Drug Administration.
Shock and ...
